J. C. Tonn

8.5k total citations · 2 hit papers
119 papers, 3.6k citations indexed

About

J. C. Tonn is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. C. Tonn has authored 119 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 37 papers in Radiology, Nuclear Medicine and Imaging and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. C. Tonn's work include Glioma Diagnosis and Treatment (75 papers), Meningioma and schwannoma management (24 papers) and Radiomics and Machine Learning in Medical Imaging (22 papers). J. C. Tonn is often cited by papers focused on Glioma Diagnosis and Treatment (75 papers), Meningioma and schwannoma management (24 papers) and Radiomics and Machine Learning in Medical Imaging (22 papers). J. C. Tonn collaborates with scholars based in Germany, Switzerland and United States. J. C. Tonn's co-authors include Michael Weller, Riccardo Soffietti, Bogdana Suchorska, Guido Reifenberger, Friedrich W. Kreth, Christian la Fougère, Niklas Thon, Nathalie L. Albert, Gabriele Pöpperl and Roland Goldbrunner and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

J. C. Tonn

110 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

2016 490 citations Nathalie L. Albert, Michael Weller et al. Neuro-Oncology profile →
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

2016 339 citations Riccardo Soffietti, Matthias Preusser et al. Neuro-Oncology profile →

Peers

Countries citing papers authored by J. C. Tonn

Since Specialization

Citations

This map shows the geographic impact of J. C. Tonn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. Tonn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. Tonn more than expected).

Fields of papers citing papers by J. C. Tonn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. Tonn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. Tonn. The network helps show where J. C. Tonn may publish in the future.

Co-authorship network of co-authors of J. C. Tonn

This figure shows the co-authorship network connecting the top 25 collaborators of J. C. Tonn. A scholar is included among the top collaborators of J. C. Tonn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. C. Tonn. J. C. Tonn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TIP-01. [177Lu]Lu-DOTATATE for recurrent meningioma (LUMEN-1, EORTC-2334-BTG): study protocol for a randomized phase II trial 2025 ·Neuro-Oncology ·Nathalie L. Albert, Émeline Tabouret, Émilie Le Rhun, Felix Sahm, Julia Furtner, J. C. Tonn, Christian Alfano, José Silva, Anne-Sophie Govaerts, Thierry Gorlia, (unknown), Giuseppe Minniti, Michael Weller, Matthias Preusser	0
2	Update to the RANO Working Group and EANO recommendations for the clinical use of PET imaging in gliomas 2025 ·Neuro-Oncology ·Norbert Galldiks, J. C. Tonn, Matthias Preusser, Nathalie L. Albert	0
3	Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter? 2025 ·Neuro-Oncology Practice ·Marjolein Geurts, (unknown), Franz Koenig, Burt Nabors, David A. Reardon, J. C. Tonn, Roger Stupp, Thierry Gorlia, Michael Weller, Matthias Preusser, (unknown)	1
4	Stereotactically Guided Microsurgical Approach for Deep-Seated Eloquently Located Lesions 2025 ·Journal of Clinical Medicine ·(unknown), Sebastian Siller, Biyan Nathanael Harapan, Robert Forbrig, J. C. Tonn, (unknown), Stefanie Quach, Christian Schichor	0
5	Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group 2024 ·Neuro-Oncology ·Norbert Galldiks, Timothy J. Kaufmann, Philipp Kickingereder, Philipp Lohmann, Marion Smits, Michael C. Veronesi, Karl‐Josef Langen, Roberta Rudà, Nathalie L. Albert, Elke Hattingen, Ian Law, Markus Hutterer, Riccardo Soffietti, Michael A. Vogelbaum, Patrick Y. Wen, Michael Weller, J. C. Tonn	21
6	Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide 2024 ·Neuro-Oncology ·(unknown), (unknown), Philipp Lohmann, (unknown), Marion Smits, J. C. Tonn, Michael Weller, Norbert Galldiks, Tom J. Snijders	6
7	Astrocytomas of the spinal cord 2024 ·Neuro-Oncology Advances ·J. C. Tonn, Nico Teske, Philipp Karschnia	2
8	Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma 2024 ·Acta Neuropathologica ·Michael Weller, Jörg Felsberg, Bettina Hentschel, Dorothee Gramatzki, (unknown), Marietta Wolter, (unknown), Patrick Roth, Dietmar Krex, Ulrich Herrlinger, Manfred Westphal, J. C. Tonn, Luca Regli, Claude‐Alain Maurage, Andreas von Deimling, Torsten Pietsch, Émilie Le Rhun, Guido Reifenberger	27
9	The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind 2024 ·Clinical Cancer Research ·Philipp Karschnia, J. C. Tonn, Daniel P. Cahill	3
10	Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape 2024 ·Neuro-Oncology ·Michael Weller, Nathalie L. Albert, Norbert Galldiks, Andrea Bink, Matthias Preusser, Erik P. Sulman, Valérie Treyer, Patrick Y. Wen, J. C. Tonn, Émilie Le Rhun	6
11	The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase–Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3 2024 ·Neurosurgery ·Jonathan Weller, (unknown), (unknown), Alba Corell, (unknown), (unknown), Niloufar Javanmardi, Niklas Thon, J. C. Tonn, Asgeir Store Jakola	1
12	Perifocal Edema in Patients with Meningioma is Associated with Impaired Whole-Brain Connectivity as Detected by Resting-State fMRI 2023 ·American Journal of Neuroradiology ·Veit M. Stoecklein, (unknown), (unknown), Niklas Thon, (unknown), Regina Schinner, Hanna Zimmermann, Thomas Liebig, Jens Ricke, Hesheng Liu, J. C. Tonn, Christian Schichor, Sophia Stoecklein	5
13	Deep Learning–based Identification of Brain MRI Sequences Using a Model Trained on Large Multicentric Study Cohorts 2023 ·Radiology Artificial Intelligence ·(unknown), Chandrakanth Jayachandran Preetha, (unknown), J. C. Tonn, Michael Weller, Wolfgang Wick, Martin Bendszus, Gianluca Brugnara, Philipp Kickingereder	5
14	Investigational PET tracers in neuro-oncology—What’s on the horizon? A report of the PET/RANO group 2022 ·Neuro-Oncology ·Norbert Galldiks, Karl‐Josef Langen, Nathalie L. Albert, Ian Law, Michelle M. Kim, Javier Villanueva-Meyer, Riccardo Soffietti, Patrick Y. Wen, Michael Weller, J. C. Tonn	18
15	Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET 2020 ·Clinical Nuclear Medicine ·Franziska Vettermann, Marcus Unterrainer, Viktoria Ruf, Daniel F. Fleischmann, Rainer Rupprecht, Robert Forbrig, Jochen Herms, J. C. Tonn, Claus Belka, Peter Bartenstein, Maximilian Niyazi, Nathalie L. Albert	4
16	Biological tumour volumes of gliomas in early and standard 20–40 min 18F-FET PET images differ according to IDH mutation status 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marcus Unterrainer, I. Winkelmann, Bogdana Suchorska, Armin Giese, Vera Wenter, Friedrich-Wilhelm Kreth, Jochen Herms, Peter Bartenstein, J. C. Tonn, Nathalie L. Albert	28
17	Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy 2013 ·Annals of Oncology ·Friedrich-Wilhelm Kreth, Niklas Thon, Matthias Simon, Manfred Westphal, Gabriele Schackert, Guido Nikkhah, Bettina Hentschel, Guido Reifenberger, Torsten Pietsch, Michael Weller, J. C. Tonn	164
18	Awake craniotomy for monitoring of language function: benefits and limits 2007 ·Acta Neurochirurgica ·J. C. Tonn	19
19	Model Systems in Neurooncology 2002 ·PubMed ·J. C. Tonn	12
20	Die isolierte Leberperfusion bei fortgeschrittenen Metastasen kolorektaler Karzinome 1984 ·Oncology Research and Treatment ·Karl Reinhard Aigner, (unknown), J. C. Tonn, K.H. Link, Paul E. Schoch, K. Schwemmle	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact